Ii.1 Tamoxifen's oestrogen-like effects in a breast cancer chemoprevention trial

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Powles, T J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TAMOXIFEN;

ADULT; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; FEMALE; HOT FLUSH; HUMAN; HUMAN EXPERIMENT; MENSTRUAL IRREGULARITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA DISCHARGE;

EID: 0031695125     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00090-2     Document Type: Conference Paper

References (5)

1. Early Breast Cancer Triallists' Collaborative Group E. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992, 339, 1-15.
2. Powles T, Hardy J, Ashley S, et al. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989, 60, 126-131.
3. Jones A, Powles T, Treleaven J, et al. Haemostatic changes in thromboembolic risk during tamoxifen therapy in normal women. Br J Cancer 1992, 66, 744-747.
4. Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S. Effect of tamoxifen on bone mineral density measured by dual energy X-ray absorptiometry in healthy pre-menopausal and post-menopausal women. J Clin Oncol 1996, 14, 78-84.
5. Chang J, Powles T, Ashley S, Iveson T, Gregory R, Dowsett M. Variation in endometrial thickening in women with amenorrhoea on tamoxifen. Breast Cancer Res and Treat 1998, in press.